EU/US Properties Organoleptics Cosmetics Suppliers Safety Safety in use Safety references References Other Blenders Uses Occurrence Synonyms Articles Notes
 

peg-400
poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy- (400 mol EO average molar ratio)

Supplier Sponsors

CAS Number: 25322-68-3Picture of molecule3D/inchi
FDA UNII: Search
Category:binding, emulsion stabilising agents
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar:Search
Google Books:Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents:Search
US Patents:Search
EU Patents:Search
PubMed:Search
NCBI:Search
 
Physical Properties:
Assay: 95.00 to 100.00
Food Chemicals Codex Listed: No
Soluble in:
 water, 1e+006 mg/L @ 25 °C (est)
 
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found).
 
Cosmetic Information:
CosIng:cosmetic data
Cosmetic Uses: binding agents
emulsion stabilisers
 
Suppliers:
Graham Chemical
PEG 400
Penta International
POLYETHYLENE GLYCOL 400 FCC
Silver Fern Chemical
Polyethylene Glycol (PEG) 400
Odor: characteristic
Use: PEG 400 has a relatively low toxicity and is used in many pharmaceutical applications. Recently, it has received attention from the electronic cigarette industry. PEG 400 is also used in plasticizers, polishes, paper coatings, lubricants, binders, metals and rubbers, additives to food and animal feed, and as a laboratory reagent.
 
Safety Information:
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
intravenous-dog LDLo 3000 mg/kg
Journal of Pharmacology and Experimental Therapeutics. Vol. 103, Pg. 293, 1951.

oral-guinea pig LD50 15700 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-guinea pig LD50 17000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-guinea pig LD50 19600 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-guinea pig LD50 22500 mg/kg
Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 349, 1950.

oral-guinea pig LD50 28000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-guinea pig LD50 28900 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-guinea pig LD50 50000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-guinea pig LD50 50900 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-mouse LD50 473 mg/kg
Yaoxue Tongbao. Bulletin of Pharmacology. Vol. 21, Pg. 387, 1986.

intraperitoneal-mouse LD50 2000 mg/kg
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Journal of Pharmacology and Experimental Therapeutics. Vol. 103, Pg. 293, 1951.

intraperitoneal-mouse LD50 7500 mg/kg
National Technical Information Service. Vol. AD628-313

intraperitoneal-mouse LD50 8000 mg/kg
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Journal of Pharmacology and Experimental Therapeutics. Vol. 103, Pg. 293, 1951.

intravenous-mouse LD50 7900 ug/kg
Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 316, 1970.

intravenous-mouse LD50 8550 mg/kg
Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 1581, 1976.

intravenous-mouse LD50 16000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-mouse LD50 28915 mg/kg
Proceedings of the European Society of Toxicology. Vol. 17, Pg. 351, 1976.

oral-mouse LD50 31000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-mouse LD50 34000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-mouse LD50 36000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

intravenous-rabbit LD50 8000 mg/kg
BLOOD: CHANGE IN CLOTTING FACTORS
Kriobiologiya i Kriomeditsina. Cryobiology and Cryomedicine. Vol. 4, Pg. 71, 1978.

oral-rabbit LD50 14000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-rabbit LD50 17300 mg/kg
International Journal of Toxicology. Vol. 18(Suppl

oral-rabbit LD50 17300 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rabbit LD50 19000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-rabbit LD50 26800 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rabbit LD50 28900 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rabbit LD50 76000 mg/kg
International Journal of Toxicology. Vol. 18(Suppl

oral-rabbit LD50 76000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD > 4000 mg/kg
Union Carbide Data Sheet. Vol. 9/25/1969

intraperitoneal-rat LD50 6790 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50 9000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50 9700 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3849, 1982.

intraperitoneal-rat LD50 9708 mg/kg
Proceedings of the European Society of Toxicology. Vol. 17, Pg. 351, 1976.

intraperitoneal-rat LD50 12600 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50 14100 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3849, 1982.

intraperitoneal-rat LD50 15390 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50 15570 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50 16000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50 17000 mg/kg
Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 349, 1950.

intraperitoneal-rat LD50 17700 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intravenous-rat LD50 7130 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3849, 1982.

intravenous-rat LD50 7312 mg/kg
Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 1581, 1976.

intravenous-rat LD50 7500 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3849, 1982.

intravenous-rat LD50 13000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50 600 mg/kg
Dow Chemical Company Reports. Vol. MSD-94

oral-rat LD50 1054 mg/kg
Dow Chemical Company Reports. Vol. MSD-95

oral-rat LD50 > 4000 mg/kg
Dow Chemical Company Reports. Vol. MSD-938

oral-rat LD50 22000 mg/kg
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 747, 1969.

oral-rat LD50 27500 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50 28000 mg/kg
Dow Chemical Company Reports. Vol. MSD-1112

oral-rat LD50 30000 mg/kg
Dow Chemical Company Reports. Vol. MSD-2203

oral-rat LD50 30200 mg/kg
Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 349, 1950.

oral-rat LD50 31600 mg/kg
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 747, 1969.

oral-rat LD50 31640 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50 32000 mg/kg
Dow Chemical Company Reports. Vol. MSD-937

oral-rat LD50 44200 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50 45000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-rat LD50 50000 mg/kg
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 747, 1969.

oral-rat LD50 > 50000 mg/kg
Dow Chemical Company Reports. Vol. MSD-935

oral-rat LD50 > 50000 mg/kg
Dow Chemical Company Reports. Vol. MSD-940

oral-rat LD50 50000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50 51200 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50 51310 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

unreported-rat LD50 7800 mg/kg
United States Patent Document. Vol. #4767763

intravenous-rat LDLo 3 mg/kg
Toxicology and Applied Pharmacology. Vol. 16, Pg. 442, 1970.

intravenous-rat LDLo 22000 mg/kg
KIDNEY, URETER, AND BLADDER: HEMATURIA VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)
Arzneimittel-Forschung. Drug Research. Vol. 23, Pg. 1087, 1973.

Dermal Toxicity:
subcutaneous-mouse LD50 18000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

skin-rabbit LD > 1000 mg/kg
Union Carbide Data Sheet. Vol. 9/25/1969

skin-rabbit LD50 > 20 mL/kg
International Journal of Toxicology. Vol. 18(Suppl

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-1112

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-2202

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-96

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-2203

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-937

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-939

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-935

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-940

subcutaneous-rat LD50 16000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

Inhalation Toxicity:
Not determined
 
Safety in Use Information:
Category:
binding, emulsion stabilising agents
Recommendation for peg-400 usage levels up to:
 not for fragrance use.
 
Recommendation for peg-400 flavor usage levels up to:
 not for flavor use.
 
Safety References:
EPI System: View
ClinicalTrials.gov:search
Daily Med:search
NIOSH International Chemical Safety Cards:search
Chemical Carcinogenesis Research Information System:Search
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA GENetic TOXicology:Search
EPA Substance Registry Services (TSCA):25322-68-3
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
National Institute of Allergy and Infectious Diseases:Data
WGK Germany:1
Chemidplus:0025322683
 
References:
Canada Domestic Sub. List:25322-68-3
Pubchem (sid):134996364
 
Other Information:
(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
HMDB (The Human Metabolome Database):Search
MedlinePlusSupp:View
Wikipedia:View
 
Potential Blenders and core components note
None Found
 
Potential Uses:
None Found
 
Occurrence (nature, food, other):note
 not found in nature
 
Synonyms:
 poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy- (400 mol EO average molar ratio)
 polyethylene glycol (400)
 polyoxyethylene (400)
 
 
Notes:
a tasteless laxative composed of peg3350; miralax is tradename. polymers of ethylene oxide and water and their ethers. they vary in consistency from liquid to solid, depending on the molecular weight, indicated by a number following the name. they are used as surfactants, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. some specific groups are lauromagrogols, nonoxynols, octoxynols and poloxamers.
Please share your Comments.
Email Address:
Top of Page Home
Copyright © 1980-2021 The Good Scents Company (tgsc) ™ Disclaimer Privacy Policy